Fundraising Fox
Navitor Pharmaceuticals
Cambridge, US · Founded 2010 · Delaware corporation · 7 employees on LinkedIn · 6 known investors
Find your way into Navitor Pharmaceuticals
Sign up to see every warm intro you have to Navitor Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Navitor Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
JF
AC
MN
BG
VP
Vinzenz PloererBoard director
DM
David MaddenBoard director
PF
Paul FriedmanBoard director
BB
Barry BurgdorfBoard director
Investors · 6
age1listed by age1San Francisco · $500K – $4M
How we know: age1's portfolio page · Not right? Tell us
Brace Pharmalisted by Brace PharmaAtlanta
How we know: Brace Pharma's portfolio page · Not right? Tell us
Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M
How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Atlas VenturereportedCambridge · $500K – $1Mvia Kevin Bitterman · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Polaris PartnersreportedBoston · $500K – $5Mvia Alan Crane · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$68.2M disclosed across 5 rounds · 2013–2020
▶$20.2MraisedMay 2020 · 19 investors · PharmaceuticalsRule 506(b)
▶$20.2MraisedMay 2020 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rajeev DadooDirector
- David MaddenDirector
- Georg VlasukDirector
- Kevin BittermanDirector
- John CreecyExecutive Officer, Director
- Marian NakadaDirector
- Vinzenz PloererDirector
- Alan CraneDirector
- Richard LundbergExecutive Officer
- Thomas HughesExecutive Officer
- Offering amount
- $20.2M
- Amount sold
- $20.2M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.3MraisedJan 2019 · 12 investors · PharmaceuticalsRule 506(b)
▶$11.3MraisedJan 2019 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alan CraneDirector
- David MaddenDirector
- George P. VlasukExecutive Officer, Director
- Rick LundbergExecutive Officer
- Kevin BittermanDirector
- Rajeev DadooDirector
- Marian Nakada, Ph.D.Director
- Thomas HughesExecutive Officer, Director
- Vinzenz PloererDirector
- John CreecyDirector
- Offering amount
- $11.3M
- Amount sold
- $11.3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.3MraisedMar 2018 · 12 investors · PharmaceuticalsRule 506(b)
▶$11.3MraisedMar 2018 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George P. VlasukExecutive Officer, Director
- Vinzenz PloererDirector
- John CreecyDirector
- David MaddenDirector
- Alan CraneDirector
- Brian Gallagher, Ph.D.Director
- Rick LundbergExecutive Officer
- Paul Friedman, M.D.Director
- Marian Nakada, Ph.D.Director
- Kevin BittermanDirector
- Offering amount
- $25M
- Amount sold
- $11.3M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedDec 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$12MraisedDec 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Francois FormelaDirector
- Rick LundbergExecutive Officer
- Alan CraneDirector
- David MaddenDirector
- Marian NakadaDirector
- Brian GallagherDirector
- Paul FriedmanDirector
- George P. VlasukExecutive Officer, Director
- Barry BurgdorfDirector
- Vinzenz PloererDirector
- Offering amount
- $33.3M
- Amount sold
- $12M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$13.5MraisedAug 2014 · 10 investors · PharmaceuticalsRule 506(b)
▶$13.5MraisedAug 2014 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rick LundbergExecutive Officer
- George VlasukExecutive Officer, Director
- Brian GallagherDirector
- Alan CraneDirector
- Marian NakadaDirector
- Jean-Francois FormelaDirector
- Offering amount
- $23.5M
- Amount sold
- $13.5M
- First sale
- Sep 2013
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Navitor Pharmaceuticals went on to found or lead other companies.
Frequently asked questions
- Who are Navitor Pharmaceuticals's investors?
- Navitor Pharmaceuticals's investors include age1, Brace Pharma, Sanofi Ventures, Atlas Venture, Polaris Partners, SR One Capital Management.
- How much funding has Navitor Pharmaceuticals raised?
- Navitor Pharmaceuticals has disclosed $68.2M raised across 5 rounds.
- Where is Navitor Pharmaceuticals headquartered?
- Navitor Pharmaceuticals is headquartered in Cambridge, US.